Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

Bone Marrow Transplantation

Volumn 26, Issue 8, 2000, Pages 911-915

  Veelken, H ^a   Wasch, R ^a   Behringer, D ^a   Bertz, H ^a   Finke, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Fludarabine; Isoaglutinins; Red cell aplasia; Reduced conditioning

Indexed keywords

AGGLUTININ; BLEOMYCIN; CARMUSTINE; CD14 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA; DOXORUBICIN; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HLA ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 3; MELPHALAN; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMA PROTEIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ALLOGRAFT; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL LINEAGE; CHEMOPROPHYLAXIS; DRUG ACTIVITY; ERYTHROCYTE COUNT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SEROLOGY; T LYMPHOCYTE;

EID: 0033753941     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702629     Document Type: Article

References (11)

1. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
2. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
3. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
4. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment
5. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
6. Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalane and allogeneic transplantation
7. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors
8. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
9. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation
10. Lymphocyte-selective cytostatic and immunosuppressive effect of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion
11. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and FK506